| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
75,919 |
43,836 |
$2.61M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13,076 |
9,210 |
$915K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
14,927 |
10,056 |
$884K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
12,485 |
8,116 |
$722K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,100 |
7,103 |
$698K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
31,275 |
20,321 |
$268K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,351 |
3,612 |
$238K |
| 97802 |
|
34,521 |
22,411 |
$172K |
| 99401 |
|
32,006 |
19,807 |
$123K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,658 |
904 |
$70K |
| 90461 |
|
13,812 |
8,230 |
$59K |
| 99381 |
|
1,334 |
771 |
$49K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
13,676 |
8,425 |
$42K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,241 |
1,350 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
11,299 |
3,094 |
$33K |
| 99383 |
|
1,048 |
478 |
$28K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
666 |
534 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
275 |
237 |
$17K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,284 |
4,402 |
$16K |
| 99051 |
|
7,221 |
5,194 |
$14K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
19,808 |
12,476 |
$14K |
| 99384 |
|
494 |
214 |
$13K |
| 99382 |
|
162 |
122 |
$12K |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
3,599 |
2,378 |
$5K |
| 96127 |
|
7,951 |
4,236 |
$4K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
235 |
105 |
$3K |
| 83655 |
|
1,351 |
964 |
$2K |
| 92551 |
|
28,665 |
18,022 |
$1K |
| 0071A |
|
39 |
36 |
$1K |
| 90716 |
|
4,398 |
3,010 |
$1K |
| 87807 |
|
269 |
177 |
$980.11 |
| 3074F |
|
27,573 |
14,794 |
$950.38 |
| 0072A |
|
25 |
24 |
$817.96 |
| 98929 |
|
43 |
39 |
$716.22 |
| 90680 |
|
4,554 |
2,917 |
$600.00 |
| A4614 |
Peak expiratory flow rate meter, hand held |
323 |
145 |
$365.00 |
| 90707 |
|
4,276 |
2,941 |
$352.39 |
| 90681 |
|
248 |
209 |
$350.00 |
| 90670 |
|
6,684 |
4,350 |
$270.08 |
| 90633 |
|
4,533 |
3,153 |
$269.73 |
| 90700 |
|
11,207 |
7,416 |
$216.47 |
| 90713 |
|
9,148 |
5,948 |
$206.51 |
| 99173 |
|
29,127 |
18,109 |
$166.13 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
582 |
523 |
$144.09 |
| 90620 |
|
951 |
444 |
$123.76 |
| 96160 |
|
336 |
109 |
$122.40 |
| 90651 |
|
4,181 |
2,624 |
$100.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
74 |
12 |
$53.22 |
| 90715 |
|
2,271 |
1,381 |
$20.01 |
| 90686 |
|
2,026 |
1,367 |
$10.03 |
| 90744 |
|
4,140 |
2,728 |
$10.00 |
| 91307 |
|
135 |
103 |
$0.25 |
| 90671 |
|
1,316 |
937 |
$0.02 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
4,140 |
2,031 |
$0.00 |
| 36416 |
|
1,084 |
804 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
777 |
563 |
$0.00 |
| 90733 |
|
159 |
158 |
$0.00 |
| 99000 |
|
105 |
96 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
97 |
41 |
$0.00 |
| 3079F |
|
159 |
48 |
$0.00 |
| 3075F |
|
80 |
30 |
$0.00 |
| 90648 |
|
8,108 |
5,395 |
$0.00 |
| 99072 |
|
9,841 |
6,612 |
$0.00 |
| 3078F |
|
27,290 |
14,532 |
$0.00 |
| 90734 |
|
3,790 |
2,359 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
386 |
201 |
$0.00 |
| 99177 |
|
429 |
268 |
$0.00 |
| 99421 |
|
421 |
358 |
$0.00 |
| 90649 |
|
187 |
173 |
$0.00 |
| 90685 |
|
26 |
26 |
$0.00 |
| 90710 |
|
64 |
13 |
$0.00 |